Table 4. Warfarin rats.
Warfarin 1.5 mg/kg i.g. once daily for 3 consecutive days | Bleeding time | Amount of bleeding | PLT before | PLT after | HCT before | HCT after | PT | APTT | TT | FIB |
---|---|---|---|---|---|---|---|---|---|---|
Tail amputation | min | mL | x109/L | x109/L | L/L | L/L | ratio (PR) | ratio | sec | g/L |
Control | >60 | 6.58± 1.2 | 612± 72 | 302± 79 | 0.441± 0.04 | 0.364± 0.02 | <0.05 | 2.86± 0.42 | 62± 6 | 1.5± 0.15 |
BPC ug | 48.6± 15* | 5.52± 1.4* | 693± 68* | 456± 116* | 0.461± 0.03 | 0.417± 0.02* | <0.05 | 2.81± 0.38 | 60± 7 | 1.7± 0.25 |
BPC ng | >60 | 5.65± 1.1* | 706± 88* | 418± 105* | 0.465± 0.02 | 0.420± 0.03* | <0.05 | 2.83± 0.47 | 58± 8 | 1.5± 0.21 |
L-arginine | >60 | 7.8± 1.4 | 638± 89 | 525± 98* | 0.521± 0.06 | 0.455± 0.04 | <0.05 | 2.03± 0.36 | 59.9± 8 | 1.9± 0.19 |
L-NAME | >60 | 8.0± 1.8 | 654± 49 | 346± 59 | 0.454± 0.03 | 0.413± 0.03 | <0.05 | 2.60± 0.39 | 62.6± 7 | 1.8± 0.17 |
L-NAME+ L-arginine | >60 | 7.0± 1.7 | 483± 87* | 283± 35 | 0.467± 0.04 | 0.415± 0.03 | <0.05 | 2.68± 0.34 | 60.6± 8 | 1.8± 0.21 |
L-arginine+ BPC 157 ug | >60 | 4.9± 0.6* | 650± 105 | 514± 119* | 0.476± 0.04 | 0.472± 0.04 | <0.05 | 2.03± 0.38 | 59.8± 8 | 1.6± 0.17 |
L-NAME+ BPC 157 ug | >60 | 5.0± 0.9* | 637± 88 | 461± 105* | 0.475± 0.04 | 0.415± 0.02 | <0.05 | 1.74± 0.29 | 60.1± 7 | 1.6± 0.15 |
L-NAME+L-arginine+ BPC 157 ug | >60 | 4.5± 0.7* | 612± 79 | 493± 113* | 0.501± 0.05 | 0.481± 0.03 | <0.05 | 1.92± 0.31 | 78.3± 12 | 1.8± 0.18 |
Tail amputation, bleeding time, amount of bleeding, PLT, HCT, PT, APTT, TT, FIB values in warfarin rats. Warfarin was given intragastrically (1.5 mg/kg) once daily for 3 consecutive days, with the last challenge was at 3 hours before the bleeding procedure. BPC 157 (10 μg/kg, 10 ng/kg) was given immediately after any warfarin challenge, intragastrically while controls received simultaneously an equivolume of saline (5.0 ml/kg intragastrically). We applied L-NAME (5 mg/kg), L-arginine (100 mg/kg) alone or combined, intraperitoneally, at 30 minutes before amputation. Mean ± SD,
*P<0.05 at least vs. control.